Brief: Lisata Therapeutics Announces Encouraging Preliminary Results From The Pancreatic Cancer Cohort
29/09/2025 13:26
Sept 29 (Reuters) - Lisata Therapeutics Inc LSTA.O: LISATA THERAPEUTICS ANNOUNCES ENCOURAGING PRELIMINARY RESULTS FROM THE PANCREATIC CANCER COHORT OF THE CENDIFOX TRIAL Source text: ID:nGNX2S5nDM Further company coverage: LSTA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics - Amends Merger Offer Price To $4 Per Share Plus CVR
Brief: Lisata Therapeutics Enters Into Definitive Agreement To Be Acquired By Kuva Labs, Inc.
U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies
Lisata jumps as Kuva Labs strikes acquisition deal